ADVENT CAPITAL MANAGEMENT /DE/
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1097278
NEW YORK, NY
Position in ESPR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
50,000
-44.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Derivatives in ESPR
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
All Filings in ESPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 50,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | — | 100,000 | Call | Sole | 2026-02-09 | |
| 2025-12-31 | — | 90,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | — | 80,000 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||